Welcome to Pink Sheet
Create an account to read this article
Already a subscriber?
NNFA-Japan
National Nutritional Foods Association forms Japanese subsidiary to assist American supplement and health food makers doing business there. NNFA-Japan will be separate from NNFA but operate under its direction; the Newport Beach, Calif.-based association will establish a Japan office for daily duties. NNFA International Committee Chair Randy Dennin is named NNFA-Japan chair, and NNFA Exec Director Michael Ford is president. Membership will be open to all firms with a corporate presence in Japan, including companies that might not qualify for NNFA membership in the U.S
More from Japan
• By
Japan gives world-first approval recommendations to two domestically originated drugs, for insomnia and glaucoma/ocular hypertension.
• By
Japan looks set to press ahead with a reimbursement price cut for Eisai's Alzheimer's drug Leqembi following a cost-effectiveness review, despite differences with the company over methodology.
• By
Country recommends eights new drugs for approval, including six for rare diseases, and also announces macroeconomic policy the pharma industry says would enable some reimbursement prices to be raised.
• By
The 14 July deadline for the Citeline Japan Awards 2025 in Tokyo is approaching fast, so here's a reminder to take a look at the categories and criteria and be sure to get your submissions in by this date. Sponsorship opportunities and tables for the event are also available.